Valuation: Amedica Corporation

Market Cap 14.86M 13.2M 12.34M 11.25M 21.18M 1.43B 21.47M 149M 57.81M 729M 55.8M 54.59M 2.34B P/E 2026 *
-1.19x
P/E 2027 * -2.1x
Enterprise Value 14.86M 13.2M 12.34M 11.25M 21.18M 1.43B 21.47M 149M 57.81M 729M 55.8M 54.59M 2.34B EV / Sales 2026 *
5.3x
EV / Sales 2027 * 2.56x
Free-Float
77.28%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 2007-11-30
President - 2026-03-15
Director of Finance/CFO 41 2025-09-03
Director TitleAgeSince
Director/Board Member 63 2007-11-30
Director/Board Member 63 2025-04-02
Director/Board Member 72 2012-11-04
Change 5-day change 1-year change 3-year change Capi.($)
-6.84%+27.74% - - 14.86M
-1.50%-3.49%-26.92%+1.90% 171B
+0.38%-2.20%-8.70%+11.30% 110B
-0.53%+1.43%-24.87%-0.09% 106B
-0.69%-0.07%-47.78%-11.65% 75.99B
+3.42%-0.07%-0.68%+72.91% 57.3B
-0.15%-0.52%-6.62%-30.83% 48.76B
+3.44%+7.90%+19.12%+59.15% 50.19B
-0.21%+1.34%-16.10%+20.72% 41.14B
+0.15%-1.37%+30.56%-8.75% 32.56B
Average -0.24%-1.46%-9.11%+12.74% 77B
Weighted average by Cap. +0.08%-2.07%-15.72%+9.94%

Financials

2026 *2027 *
Net sales 2.8M 2.49M 2.33M 2.12M 3.99M 270M 4.05M 28.17M 10.9M 137M 10.53M 10.3M 442M 5.8M 5.15M 4.82M 4.39M 8.27M 558M 8.38M 58.29M 22.56M 284M 21.78M 21.31M 914M
Net income -11.89M -10.56M -9.88M -9M -16.95M -1.14B -17.18M -119M -46.26M -583M -44.65M -43.68M -1.87B -11.13M -9.89M -9.25M -8.43M -15.87M -1.07B -16.08M -112M -43.31M -546M -41.8M -40.9M -1.75B
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-